UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Qatar’s military to learn Korean hospital operating system
Seven officers from Qatar Armed Force Medical Command have started a month-...
by Lee Han-soo
|
2018-07-02 16:48
라인
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
Eliquis (ingredient: apixaban) by Bristol-Myers Squibb Korea and Korea Pfiz...
by Nam Doo-hyun
|
2018-07-02 16:47
라인
NCC celebrates 11 years of proton therapy saving patients
The National Cancer Center said it has reaped meaningful results in proton ...
by Song Soo-youn
|
2018-07-02 15:04
라인
SK Bioscience starts business
SK Bioscience CEO Ahn Jae-yong SK Chemicals announced on Sunday that it h...
by Lee Han-soo
|
2018-07-02 15:00
라인
Severance Hospital robotic surgeries hit 20,000
Severance Hospital said it has performed 20,000 robotic surgeries, the most...
by Lee Hye-seon
|
2018-07-02 11:53
라인
Sanofi Korea presents findings on head-to-head trial on Toujeo vs. Tresiba
Sanofi presented head-to-head trial results for Toujeo Monday. Sanofi’s d...
by Marian Chu
|
2018-06-29 18:01
라인
Genome Care to provide 2 infertility aid services
Genome Care, a subsidiary of Theragen ETEX, said Friday that it plans to la...
by Lee Han-soo
|
2018-06-29 17:29
라인
VUNO unveils SW with excellent function for predicting cardiac arrest
VUNO has released new study results, which show its artificial intelligence...
by Marian Chu
|
2018-06-29 17:29
라인
Beijing Northland to go ahead with P3 clinical trials for VM202 in China
Viromed said Friday that Beijing Northland Biotech, its Chinese partner, wi...
by Lee Han-soo
|
2018-06-29 15:44
라인
Eisai’s Aricept dominates dementia treatment market
Eisai’s Aricept has comfortably secured the No. 1 place in the local dement...
by So Jae-hyeon
|
2018-06-29 15:24
라인
BMS Korea wins fight for Eliquis patent
Bristol-Myers Squibb (BMS) Korea said it has won a suit against domestic dr...
by Nam Doo-hyun
|
2018-06-29 14:41
라인
Biogen purchases Samsung Bioepis’ share
Samsung BioLogics said Friday that Biogen has exercised its call option and...
by Lee Han-soo
|
2018-06-29 14:23
라인
Botulinum toxin makers compete to expand indications
Local developers of botulinum toxins are increasingly competing to expand t...
by So Jae-hyeon
|
2018-06-29 14:07
라인
Korean pharmaceuticals fail to invalidate Invokana patent
A three-year-long trial to invalidate the patent for Janssen’s diabetes dru...
by Marian Chu
|
2018-06-28 17:58
라인
Pfizer’s kidney cancer therapy Inlyta to be reimbursed in July
The Ministry of Health and Welfare announced Wednesday that it would add Pf...
by Lee Hye-seon
|
2018-06-28 17:57
라인
Weight-loss drug Saxenda creates marketing sensation in Korea
Saxenda (ingredient: liraglutide), an injectable drug to treat obesity, is ...
by Lee Hye-seon
|
2018-06-28 16:40
라인
Hugel, Hamni to cooperate in urology market
Hugel, a biopharmaceutical company, announced Thursday that it has entered ...
by Lee Han-soo
|
2018-06-28 16:39
라인
Herbalife Korea publishes results of genetic big data analysis
Herbalife Korea announced Thursday the results of its big data analysis of ...
by Marian Chu
|
2018-06-28 14:52
라인
Foreign doctors visit Kosin hospital for training
Foreign physicians are increasingly visiting Kosin University Gospel Hospit...
by Song Soo-youn
|
2018-06-28 14:51
라인
LG Chem launches Enbrel biosimilar in Korea
LG Chem said Wednesday that it has launched Eucept, an Enbrel biosimilar (i...
by Lee Han-soo
|
2018-06-28 12:23
-
이전
201
202
203
204
205
206
207
208
209
210
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top